Sufu Gene Meningioma Familial Susceptibility to NGS Genetic DNA Test

Introduction

The Sufu Gene Meningioma Familial Susceptibility to NGS Genetic DNA Test is a specialized genetic test that identifies mutations in the SUFU gene, which are associated with an increased risk of developing meningiomas, a type of brain tumor. Understanding your genetic predisposition can be crucial for early detection and proactive management of potential health risks.

What the Test Measures

This test detects specific genetic variations in the SUFU gene that may indicate a familial susceptibility to meningiomas. By utilizing Next-Generation Sequencing (NGS) technology, we can provide accurate results that help in understanding your genetic risk profile.

Who Should Consider This Test

Individuals who may benefit from the Sufu Gene Meningioma test include:

• Those with a family history of meningioma or related tumors.
• Patients exhibiting symptoms such as persistent headaches, vision changes, or neurological deficits.
• Individuals with known genetic predispositions to cancer.

Benefits of Taking the Test

Taking the Sufu Gene Meningioma test offers several benefits:

• Early identification of genetic risk factors for meningioma.
• Informed decision-making regarding monitoring and treatment options.
• Guidance for family members on their potential risks.
• Enhanced communication with healthcare providers regarding personalized care plans.

Understanding Your Results

After completing the test, results will typically be available within 3 to 4 weeks. A genetic counselor will help interpret your results, discussing the implications of any findings and potential next steps for you and your family.

Test Information and Pricing

Branches and Booking

We have branches across all major cities in Kenya, and we offer convenient home sample collection services. Don’t wait to take control of your health—book your test today!

For more information or to schedule your appointment, call or WhatsApp us at +254711564616.